Jiangsu Chinagreen Biological Technology Group Co.,Ltd. (SHE:300970)
China · Delayed Price · Currency is CNY 17.45
0.00 (0.00%)
At close: Sep 30, 2026
SHE:300970 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 2,728 | 2,467 | 1,402 | 2,035 | 2,077 | 3,404 | |
Market Cap Growth | 54.04% | 75.87% | -31.07% | -2.05% | -38.98% | - |
Enterprise Value | 2,885 | 2,602 | 1,691 | 1,870 | 1,782 | 2,950 |
Last Close Price | 17.45 | 15.48 | 8.98 | 12.84 | 13.12 | 21.50 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.90 | 22.37 | - | 67.05 | 26.55 | 219.56 |
PS Ratio | 1.83 | 1.91 | 1.36 | 2.04 | 2.76 | 5.89 |
PB Ratio | 1.63 | 1.48 | 0.92 | 1.30 | 1.36 | 2.37 |
P/TBV Ratio | 1.73 | 1.56 | 0.98 | 1.37 | 1.42 | 2.47 |
P/FCF Ratio | 7.87 | 11.10 | - | - | - | - |
P/OCF Ratio | 5.89 | 7.14 | 10.18 | 12.21 | 11.55 | 40.97 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.94 | 2.01 | 1.64 | 1.88 | 2.37 | 5.10 |
EV/EBITDA Ratio | 6.40 | 8.79 | 16.23 | 12.12 | 11.74 | 38.86 |
EV/EBIT Ratio | 12.30 | 19.93 | - | 50.86 | 32.51 | - |
EV/FCF Ratio | 8.32 | 11.71 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.42 | 0.34 | 0.37 | 0.21 | 0.19 | 0.21 |
Debt / EBITDA Ratio | 1.55 | 1.73 | 4.31 | 1.96 | 1.88 | 4.05 |
Debt / FCF Ratio | 2.02 | 2.57 | - | - | - | - |
Net Debt / Equity Ratio | 0.07 | -0.01 | 0.14 | -0.05 | -0.16 | -0.32 |
Net Debt / EBITDA Ratio | 0.28 | -0.06 | 1.97 | -0.50 | -1.60 | -6.10 |
Net Debt / FCF Ratio | 0.32 | -0.08 | -1.57 | 1.33 | 1.06 | 3.83 |
Asset Turnover | 0.61 | 0.54 | 0.47 | 0.49 | 0.39 | 0.38 |
Inventory Turnover | 5.17 | 5.15 | 5.11 | 5.04 | 4.77 | 5.63 |
Quick Ratio | 2.97 | 2.47 | 1.71 | 1.85 | 2.95 | 4.71 |
Current Ratio | 4.21 | 3.40 | 2.61 | 2.69 | 3.84 | 5.35 |
Return on Equity (ROE) | 14.77% | 7.47% | -2.88% | 1.71% | 5.25% | 1.42% |
Return on Assets (ROA) | 6.05% | 3.42% | -1.04% | 1.12% | 1.78% | -0.35% |
Return on Invested Capital (ROIC) | 13.68% | 7.73% | -2.29% | 2.65% | 4.72% | -0.93% |
Return on Capital Employed (ROCE) | 9.80% | 5.90% | -1.80% | 2.00% | 3.10% | -0.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.70% | 4.47% | -3.39% | 1.49% | 3.77% | 0.46% |
FCF Yield | 12.71% | 9.01% | -9.30% | -2.83% | -10.98% | -3.55% |
Dividend Yield | 2.20% | 2.48% | - | 1.20% | 1.17% | - |
Payout Ratio | 33.77% | 10.46% | - | 117.15% | 3.44% | 230.73% |
Buyback Yield / Dilution | -2.26% | -2.21% | 0.62% | 0.06% | -5.46% | -8.65% |
Total Shareholder Return | -0.06% | 0.28% | 0.62% | 1.25% | -4.29% | -8.65% |